Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
Domain	FXR_C1	FXR2 FXR1	1.06e-04	2	193	2	IPR032172
Domain	FXR_C1	FXR2 FXR1	1.06e-04	2	193	2	PF16096
Domain	FAM21	WASHC2A WASHC2C	1.06e-04	2	193	2	IPR027308
Domain	-	ZNF597 ZNF777 PEG3 ZKSCAN7 RREB1 ZNF320 GLI2 ZNF655 ZNF283 ZNF860 ZNF484 ZNF772 CREB5 RLF ZNF28 ZFHX3 PRDM15 ZNF121	2.48e-04	679	193	18	3.30.160.60
Domain	Agenet	FXR2 FXR1	3.17e-04	3	193	2	PF05641
Domain	AGENET_LIKE	FXR2 FXR1	3.17e-04	3	193	2	PS51641
Domain	BMP_1/tolloid-like	TLL1 TLL2	3.17e-04	3	193	2	IPR015446
Domain	CAP-ZIP_m	WASHC2A WASHC2C	3.17e-04	3	193	2	PF15255
Domain	FXMRP1_C_core	FXR2 FXR1	3.17e-04	3	193	2	IPR022034
Domain	Agenet-like_dom	FXR2 FXR1	3.17e-04	3	193	2	IPR008395
Domain	FAM21/CAPZIP	WASHC2A WASHC2C	3.17e-04	3	193	2	IPR029341
Domain	FXMRP1_C_core	FXR2 FXR1	3.17e-04	3	193	2	PF12235
Domain	Znf_C2H2/integrase_DNA-bd	ZNF597 ZNF777 PEG3 ZKSCAN7 RREB1 ZNF320 GLI2 ZNF655 ZNF283 ZNF860 ZNF484 ZNF772 CREB5 RLF ZNF28 ZFHX3 PRDM15 ZNF121	3.23e-04	694	193	18	IPR013087
Domain	ZINC_FINGER_C2H2_2	ZNF597 ZNF777 PEG3 ZKSCAN7 ZNF280B RREB1 ZNF320 GLI2 ZNF655 ZNF283 ZNF860 ZNF484 ZNF772 CREB5 RLF ZNF28 ZFHX3 PRDM15 ZNF121	4.42e-04	775	193	19	PS50157
Domain	ZINC_FINGER_C2H2_1	ZNF597 ZNF777 PEG3 ZKSCAN7 ZNF280B RREB1 ZNF320 GLI2 ZNF655 ZNF283 ZNF860 ZNF484 ZNF772 CREB5 RLF ZNF28 ZFHX3 PRDM15 ZNF121	4.56e-04	777	193	19	PS00028
Domain	Znf_C2H2-like	ZNF597 ZNF777 PEG3 ZKSCAN7 ZNF280B RREB1 ZNF320 GLI2 ZNF655 ZNF283 ZNF860 ZNF484 ZNF772 CREB5 RLF ZNF28 ZFHX3 PRDM15 ZNF121	6.12e-04	796	193	19	IPR015880
Domain	LLGL	STXBP5 LLGL1	6.29e-04	4	193	2	PF08366
Domain	Lethal2_giant	STXBP5 LLGL1	6.29e-04	4	193	2	IPR000664
Domain	LLGL2	STXBP5 LLGL1	6.29e-04	4	193	2	IPR013577
Domain	Znf_C2H2	ZNF597 ZNF777 PEG3 ZKSCAN7 ZNF280B RREB1 ZNF320 GLI2 ZNF655 ZNF283 ZNF860 ZNF484 ZNF772 CREB5 RLF ZNF28 ZFHX3 PRDM15 ZNF121	7.00e-04	805	193	19	IPR007087
Domain	ZnF_C2H2	ZNF597 ZNF777 PEG3 ZKSCAN7 ZNF280B RREB1 ZNF320 GLI2 ZNF655 ZNF283 ZNF860 ZNF484 ZNF772 CREB5 RLF ZNF28 ZFHX3 PRDM15 ZNF121	7.32e-04	808	193	19	SM00355
Pubmed	Hdac4 Interactions in Huntington's Disease Viewed Through the Prism of Multiomics.	SPTAN1 WASHC2A CFB ITPR1 ATXN2 NGEF C3 CHD6 ALB HSPA4 WASHC2C YWHAG CASK FXR1 KANSL1 NUP155 FMN2	3.25e-09	475	202	17	31040226
Pubmed	Proximity-dependent biotin identification (BioID) reveals a dynamic LSD1-CoREST interactome during embryonic stem cell differentiation.	RREB1 ALMS1 BRCA2 ANAPC1 CHD6 MGA OBI1 CASP8AP2 RGPD2 NELFCD RUFY1 RLF LRP1 ZFHX3 CRYBG3 PCCA	3.72e-09	418	202	16	34709266
Pubmed	Systematic bromodomain protein screens identify homologous recombination and R-loop suppression pathways involved in genome integrity.	EPC2 ATXN7L1 PEX1 CUL7 RREB1 HMG20A ALMS1 ANAPC1 MGA NOTCH2 ARMC6 ADAMTS1 FXR2 RSBN1 LRIG3 FXR1 LRP1 FMN2 ZFHX3 CRYBG3 PCCA ANKS3 RAI1 RHOT1 NIN	9.22e-09	1116	202	25	31753913
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: II. The complete nucleotide sequences of 400 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	MBTPS1 PEG3 DNAJC6 WASHC2A ZCCHC14 PLEKHG1 PER2 DENND4B CHD6 WASHC2C STXBP5 RSBN1 LRIG3 KANSL1 RUBCN	1.92e-08	407	202	15	12693553
Pubmed	Human transcription factor protein interaction networks.	EPC2 ATXN7L1 SPTAN1 MRPS27 ETV5 CUL7 RREB1 WASHC2A MYO5C HMG20A ALMS1 ATXN2 GLI2 NFYB CHD6 MGA HSPA4 RLF RSBN1 KANSL1 ZFHX3 CEP152 SSBP4 PCCA SLX4 RHOT1 ZNF121	7.55e-08	1429	202	27	35140242
Pubmed	Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes.	PRPF31 EPC2 CUL7 ANAPC1 UTP20 ALB MGA KIT OBI1 NOTCH2 ARMC6 KIF27 NELFCD AGGF1 MSH3 CREB5 FXR1 KANSL1 LRP1 PRDM15	1.62e-07	857	202	20	25609649
Pubmed	Proximity labeling of endogenous RICTOR identifies mTOR complex 2 regulation by ADP ribosylation factor ARF1.	WASHC2A MGA OBI1 RGPD2 GCFC2 WASHC2C GPATCH1 TMPO OGA RPL3L	5.86e-07	215	202	10	35973513
Pubmed	Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.	MBTPS1 ATXN7L1 OBSCN ANKMY1 CHD2 PTPN4 ATXN2 GLI2 NUP210 NGEF CHD6 NOTCH2 FAM149A HECTD4 IDE CASK RLF ABCG1 TLL1 USP40 LRP1 ZFHX3 TMEM143 PCCA PRDM15 RAI1	6.05e-07	1489	202	26	28611215
Pubmed	Virus-Host Interactome and Proteomic Survey Reveal Potential Virulence Factors Influencing SARS-CoV-2 Pathogenesis.	STIM1 UTP20 KIT HSPA4 FXR2 ERO1A RUFY1 EXOC5 FXR1 NUP155 NIN	1.01e-06	285	202	11	32838362
Pubmed	C5orf51 is a component of the MON1-CCZ1 complex and controls RAB7A localization and stability during mitophagy.	PEX1 WASHC2A ITPR1 STIM1 USP32 NOTCH2 COG2 WASHC2C STXBP5 LRIG3 NUP155 FMN2 TMPO TOR1AIP1	1.72e-06	504	202	14	34432599
Pubmed	Transcriptome characterization elucidates signaling networks that control human ES cell growth and differentiation.	PRPF31 OBSCN CHD2 WASHC2A ITPR1 ZCCHC14 MSANTD3 R3HCC1L SERINC3 KIT COL6A3 WASHC2C EXOC5 ZNF28 NSMF SHCBP1 CEP152 PRDM15 TOR1AIP1 RUBCN RHOT1 ZNF121	2.66e-06	1215	202	22	15146197
Pubmed	A protein-protein interaction network for human inherited ataxias and disorders of Purkinje cell degeneration.	ELOA2 PEG3 MIF4GD ATXN2 CHD6 HSPA4 GCFC2 WASHC2C FXR2 BEND2 SAR1A EXOC5 NSMF TMPO ANKS3	3.11e-06	608	202	15	16713569
Pubmed	WDRPUH, a novel WD-repeat-containing protein, is highly expressed in human hepatocellular carcinoma and involved in cell proliferation.	BRCA2 HSPA4 CFAP52	3.81e-06	6	202	3	15967112
Pubmed	Transcriptome analysis of mouse stem cells and early embryos.	ITGA9 ITPR1 SYDE2 CHD6 MGA OBI1 COL6A3 HECTD4 SAR1A TMPO NIN	1.01e-05	363	202	11	14691545
Pubmed	A central chaperone-like role for 14-3-3 proteins in human cells.	PRPF31 SPTAN1 STIM1 ZCCHC14 PLEKHG1 ALMS1 SYDE2 OBI1 NOTCH2 NELFCD GRK7 STIL YWHAG FXR1 FMN2 CEP152 CRYBG3	1.29e-05	861	202	17	36931259
Pubmed	Phenotypic and Interaction Profiling of the Human Phosphatases Identifies Diverse Mitotic Regulators.	SPTAN1 CUL7 ITPR1 STIM1 PTPN4 PTPRH ATXN2 NUP210 FTO PMS2 IDE YWHAG RCAN3 CASK NUP155 FMN2 TMPO CRYBG3 NIN	1.32e-05	1049	202	19	27880917
Pubmed	Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.	SPTAN1 DNAJC6 ATXN2 ANAPC1 NGEF MGA MAPK8IP1 RGPD2 FXR2 NTRK2 HECTD4 GRM2 YWHAG CASK FXR1 LRP1 EML1 RAI1	1.48e-05	963	202	18	28671696
Pubmed	Characterization of an exchangeable gene trap using pU-17 carrying a stop codon-beta geo cassette.	DNAJC6 ITPR1 PTPN4 GLI2 USP32 NFYB FTO NOTCH2 TBCEL YWHAG KANSL1 ZFHX3 CEP152	1.72e-05	536	202	13	15840001
Pubmed	Proteomic and Biochemical Comparison of the Cellular Interaction Partners of Human VPS33A and VPS33B.	RREB1 WASHC2A CEP128 PLEKHG1 CEP97 WASHC2C THUMPD3 CEP152 NIN	1.77e-05	251	202	9	29778605
Pubmed	Exchangeable gene trap using the Cre/mutated lox system.	DNAJC6 ITPR1 PTPN4 GLI2 USP32 NFYB FTO NOTCH2 TBCEL YWHAG KANSL1 ZFHX3 CEP152	1.78e-05	538	202	13	10512203
Pubmed	E-cadherin expression on multiple myeloma cells activates tumor-promoting properties in plasmacytoid DCs.	INPP5D HSPA4 MSH3 TMPO	2.03e-05	28	202	4	30277474
Pubmed	Construction of long-transcript enriched cDNA libraries from submicrogram amounts of total RNAs by a universal PCR amplification method.	ANO9 AHI1 PEG3 OBSCN PEX1 CHD2 ITGA9 WASHC2A ITPR1 ZNF655 SERINC3 MGA PMS2 WASHC2C ERO1A FXR1 FMN2 CCDC171 SLX4	2.07e-05	1084	202	19	11544199
Pubmed	The STUbL RNF4 regulates protein group SUMOylation by targeting the SUMO conjugation machinery.	ZNF597 CHD2 STIM1 ZNF320 ATXN2 ANAPC1 GLI2 ZNF655 NUP210 ZNF283 MGA NOTCH2 CREB5 RLF RSBN1 ZNF28 NUP155 LRP1 TMPO SLX4	2.64e-05	1203	202	20	29180619
Pubmed	Proximity biotinylation and affinity purification are complementary approaches for the interactome mapping of chromatin-associated protein complexes.	EPC2 SPTAN1 ALMS1 C3 CHD6 ALB DNMT3A PMS2 RLF CEP152 PRDM15 TOR1AIP1 RAI1 NIN	2.77e-05	645	202	14	25281560
Pubmed	An antibody-based proximity labeling map reveals mechanisms of SARS-CoV-2 inhibition of antiviral immunity.	PRPF31 RREB1 WASHC2A ZCCHC14 ALMS1 ANAPC1 CHD6 MGA GCFC2 FXR2 ERO1A SAR1A RCAN3 FXR1 TOR1AIP1	2.81e-05	733	202	15	34672954
Pubmed	Proximity interactions among centrosome components identify regulators of centriole duplication.	CEP128 ALMS1 CEP97 STIL CEP152 NIN	2.86e-05	101	202	6	24613305
Pubmed	E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins.	OBSCN CHD2 R3HCC1L SYDE2 DENND4B ATAD2B UTP20 CHD6 ALB FXR2 RCAN3 LOXHD1 FMN2 TMPO RAI1	2.95e-05	736	202	15	29676528
Pubmed	Prediction of the coding sequences of unidentified human genes. XV. The complete sequences of 100 new cDNA clones from brain which code for large proteins in vitro.	ZNF777 NBPF12 ATXN7L1 PLEKHG1 ATAD2B KANSL1	3.19e-05	103	202	6	10574462
Pubmed	Obscurin regulates the organization of myosin into A bands.	MYH2 OBSCN	3.36e-05	2	202	2	15013951
Pubmed	Lessons from functional and structural analyses of disease-associated genetic variants in the complement alternative pathway.	CFB C3	3.36e-05	2	202	2	20837143
Pubmed	Metabolism of activated complement component C3 is mediated by the low density lipoprotein receptor-related protein/alpha(2)-macroglobulin receptor.	C3 LRP1	3.36e-05	2	202	2	10608878
Pubmed	Complement activation in patients with isolated antiphospholipid antibodies or primary antiphospholipid syndrome.	CFB C3	3.36e-05	2	202	2	22234447
Pubmed	Control of HIV replication in astrocytes by a family of highly conserved host proteins with a common Rev-interacting domain (Risp).	WASHC2A WASHC2C	3.36e-05	2	202	2	20827171
Pubmed	Attenuation of experimental autoimmune demyelination in complement-deficient mice.	CFB C3	3.36e-05	2	202	2	11067947
Pubmed	FAM21 is critical for TLR2/CLEC4E-mediated dendritic cell function against Candida albicans.	WASHC2A WASHC2C	3.36e-05	2	202	2	36717248
Pubmed	Induction of Ocular Complement Activation by Inflammatory Stimuli and Intraocular Inhibition of Complement Factor D in Animal Models.	CFB C3	3.36e-05	2	202	2	29450541
Pubmed	Complement deficiency ameliorates collagen-induced arthritis in mice.	CFB C3	3.36e-05	2	202	2	12077276
Pubmed	Quantitative Modeling of the Alternative Pathway of the Complement System.	CFB C3	3.36e-05	2	202	2	27031863
Pubmed	Targeted genotyping of COVID-19 patients reveals a signature of complement C3 and factor B coding SNPs associated with severe infection.	CFB C3	3.36e-05	2	202	2	36805858
Pubmed	Zfhx3-mediated genetic ablation of the SCN abolishes light entrainable circadian activity while sparing food anticipatory activity.	PER2 ZFHX3	3.36e-05	2	202	2	34632336
Pubmed	Electroluminescent TCC, C3dg and fB/Bb epitope assays for profiling complement cascade activation in vitro using an activated complement serum calibration standard.	CFB C3	3.36e-05	2	202	2	24287422
Pubmed	Association of the IP3R to STIM1 provides a reduced intraluminal calcium microenvironment, resulting in enhanced store-operated calcium entry.	ITPR1 STIM1	3.36e-05	2	202	2	30185837
Pubmed	Comparative genomic sequence analysis of the FXR gene family: FMR1, FXR1, and FXR2.	FXR2 FXR1	3.36e-05	2	202	2	11735223
Pubmed	Enforced differentiation of Dnmt3a-null bone marrow leads to failure with c-Kit mutations driving leukemic transformation.	KIT DNMT3A	3.36e-05	2	202	2	25416276
Pubmed	Transient receptor potential ankyrin-1 (TRPA1) modulates store-operated Ca(2+) entry by regulation of STIM1-Orai1 association.	STIM1 TRPA1	3.36e-05	2	202	2	23994313
Pubmed	Preimplantation embryos cooperate with oviductal cells to produce embryotrophic inactivated complement-3b.	CFB C3	3.36e-05	2	202	2	18039777
Pubmed	Ovarian steroid-regulated synthesis and secretion of complement C3 and factor B in mouse endometrium during the natural estrous cycle and pregnancy period.	CFB C3	3.36e-05	2	202	2	11804945
Pubmed	Altered cognitive performance and synaptic function in the hippocampus of mice lacking C3.	CFB C3	3.36e-05	2	202	2	24378428
Pubmed	Coordinated roles of SLX4 and MutSβ in DNA repair and the maintenance of genome stability.	MSH3 SLX4	3.36e-05	2	202	2	33596761
Pubmed	Critical role of complement and viral evasion of complement in acute, persistent, and latent gamma-herpesvirus infection.	CFB C3	3.36e-05	2	202	2	12196286
Pubmed	Identification of the C3b binding site in a recombinant vWF-A domain of complement factor B by surface-enhanced laser desorption-ionisation affinity mass spectrometry and homology modelling: implications for the activity of factor B.	CFB C3	3.36e-05	2	202	2	10610782
Pubmed	Initiation of the alternative pathway of complement: recognition of activators by bound C3b and assembly of the entire pathway from six isolated proteins.	CFB C3	3.36e-05	2	202	2	279011
Pubmed	RNA N6-methyladenosine demethylase FTO targets MOXD1 promoting the malignant phenotype of gastric cancer.	FTO MOXD1	3.36e-05	2	202	2	38200441
Pubmed	Complement activation by both classical and alternative pathways is critical for the effector phase of arthritis.	CFB C3	3.36e-05	2	202	2	15048732
Pubmed	SHIP represses Th2 skewing by inhibiting IL-4 production from basophils.	INPP5D KIT	3.36e-05	2	202	2	21131429
Pubmed	Structural studies of the tandem Tudor domains of fragile X mental retardation related proteins FXR1 and FXR2.	FXR2 FXR1	3.36e-05	2	202	2	21072162
Pubmed	Neutralizing antichlamydial activity of complement by chlamydia-secreted protease CPAF.	CFB C3	3.36e-05	2	202	2	27436813
Pubmed	Prepregnancy obesity and complement system activation in early pregnancy and the subsequent development of preeclampsia.	CFB C3	3.36e-05	2	202	2	22542119
Pubmed	Different targets for the fragile X-related proteins revealed by their distinct nuclear localizations.	FXR2 FXR1	3.36e-05	2	202	2	10196376
Pubmed	SHIP1 is a repressor of mast cell hyperplasia, cytokine production, and allergic inflammation in vivo.	INPP5D KIT	3.36e-05	2	202	2	19542434
Pubmed	Analysis of albumin-associated peptides and proteins from ovarian cancer patients.	BRCA2 ALB	3.36e-05	2	202	2	16099937
Pubmed	Distinct tissue site-specific requirements of mast cells and complement components C3/C5a receptor in IgG immune complex-induced injury of skin and lung.	C3 KIT	3.36e-05	2	202	2	11441111
Pubmed	Identification of a novel Rev-interacting cellular protein.	WASHC2A WASHC2C	3.36e-05	2	202	2	15847701
Pubmed	The Alternative Complement System Mediates Cell Death in Retinal Ischemia Reperfusion Injury.	CFB C3	3.36e-05	2	202	2	30174588
Pubmed	TRPA1-dependent pruritus in IL-13-induced chronic atopic dermatitis.	KIT TRPA1	3.36e-05	2	202	2	24140646
Pubmed	Differences in signaling pathways and expression level of the phosphoinositide phosphatase SHIP1 between two oncogenic mutants of the receptor tyrosine kinase KIT.	INPP5D KIT	3.36e-05	2	202	2	15990278
Pubmed	The role of properdin in the assembly of the alternative pathway C3 convertases of complement.	CFB C3	3.36e-05	2	202	2	16301317
Pubmed	Functional basis of protection against age-related macular degeneration conferred by a common polymorphism in complement factor B.	CFB C3	3.36e-05	2	202	2	19255449
Pubmed	TrkB-mediated protection against circadian sensitivity to noise trauma in the murine cochlea.	PER2 NTRK2	3.36e-05	2	202	2	24583017
Pubmed	Notch2 signaling is required for proper mast cell distribution and mucosal immunity in the intestine.	KIT NOTCH2	3.36e-05	2	202	2	20971948
Pubmed	Multiple bone morphogenetic protein 1-related mammalian metalloproteinases process pro-lysyl oxidase at the correct physiological site and control lysyl oxidase activation in mouse embryo fibroblast cultures.	TLL1 TLL2	3.36e-05	2	202	2	11313359
Pubmed	Comparative host-coronavirus protein interaction networks reveal pan-viral disease mechanisms.	MRPS27 PEX1 CEP128 STIM1 TM9SF2 IMP4 NUP210 UTP20 ADAMTS1 FXR2 ERO1A IDE FXR1 TOR1AIP1 NIN	3.88e-05	754	202	15	33060197
Pubmed	The human cytoplasmic dynein interactome reveals novel activators of motility.	WASHC2A CEP128 PLEKHG1 ALMS1 BRCA2 MGA CEP97 WASHC2C FXR2 STXBP5 GPATCH1 STIL RUFY1 CEP152 PCCA NIN	4.31e-05	853	202	16	28718761
Pubmed	Interaction network of human early embryonic transcription factors.	EPC2 RREB1 ALMS1 ALB MGA MSH3 RLF ZFHX3 SLX4 RAI1	4.33e-05	351	202	10	38297188
Pubmed	Functional proteomics mapping of a human signaling pathway.	HMG20A TM9SF2 CHD6 MGA NOTCH2 ZNF484 NELFCD CASK RLF KANSL1 NUP155 LRP1 RUBCN	4.69e-05	591	202	13	15231748
Pubmed	Systematic analysis of human protein complexes identifies chromosome segregation proteins.	PRPF31 WASHC2A ITPR1 PER2 ANAPC1 OBI1 CEP97 RGPD2 WASHC2C AGGF1 IDE CWC22 KANSL1 NUP155 SHCBP1 TMPO CEP152 TOR1AIP1 SLX4	4.88e-05	1155	202	19	20360068
Pubmed	Defining the proximal interaction networks of Arf GTPases reveals a mechanism for the regulation of PLD1 and PI4KB.	STIM1 SYDE2 ALB MGA NOTCH2 GPATCH1 RUFY1 SAR1A CASK LRIG3 NUP155 TMPO ZFHX3 PCCA TOR1AIP1	5.44e-05	777	202	15	35844135
Pubmed	Reciprocal interaction between SIRT6 and APC/C regulates genomic stability.	ITPR1 ANAPC1 IMP4 NUP210 HSPA4 FXR2 GPATCH1 HECTD4 FXR1 NUP155 SLX4	5.87e-05	440	202	11	34244565
Pubmed	Comprehensive interactome profiling of the human Hsp70 network highlights functional differentiation of J domains.	SPTAN1 MRPS27 DNAJC6 WASHC2A ITPR1 STIM1 PLEKHG1 R3HCC1L NUP210 HSPA4 NOTCH2 CASP8AP2 ERO1A CASK EXOC5 LLGL1 NUP155 TMPO CRYBG3 OGA TOR1AIP1 NIN	5.93e-05	1487	202	22	33957083
Pubmed	The in vivo Interaction Landscape of Histones H3.1 and H3.3.	PRPF31 CHD2 RREB1 HMG20A ATAD2B CHD6 MGA DNMT3A MSH3 RLF TMPO PRDM15 RAI1	6.25e-05	608	202	13	36089195
Pubmed	Chr21 protein-protein interactions: enrichment in proteins involved in intellectual disability, autism, and late-onset Alzheimer's disease.	SPTAN1 PEG3 ITGB8 HMG20A ZNF655 USP32 NGEF CHD6 MAPK8IP1 COG2 PMS2 ADAMTS1 HECTD4 MSH3 YWHAG CASK NSMF LRP1 FMN2 SLX4	6.59e-05	1285	202	20	35914814
Pubmed	Large-scale genotyping identifies 41 new loci associated with breast cancer risk.	ITPR1 BRCA2 ZNF283 FTO SSBP4	8.32e-05	76	202	5	23535729
Pubmed	Extensive proteomic screening identifies the obesity-related NYGGF4 protein as a novel LRP1-interactor, showing reduced expression in early Alzheimer's disease.	NAPG MAPK8IP1 LRP1	8.34e-05	15	202	3	20205790
Pubmed	Genome-wide association study of advanced age-related macular degeneration identifies a role of the hepatic lipase gene (LIPC).	RREB1 CFB C3	8.34e-05	15	202	3	20385826
Pubmed	Evaluation of 172 candidate polymorphisms for association with oligozoospermia or azoospermia in a large cohort of men of European descent.	SYCP2 BRCA2 KIT TEX15	8.57e-05	40	202	4	20378615
Pubmed	Novel genetic loci identified for the pathophysiology of childhood obesity in the Hispanic population.	ATXN7L1 ITPR1 PLEKHG1 TM9SF2 ANAPC1 ATAD2B C2orf42 GTDC1 RSBN1 MOXD1 GUCY1A2 TLL1 CEP152 MYO16 RHOT1	9.13e-05	814	202	15	23251661
Pubmed	A negative genetic interaction map in isogenic cancer cell lines reveals cancer cell vulnerabilities.	PRPF31 ATXN7L1 RREB1 CFB ALMS1 STIL CWC22	9.30e-05	180	202	7	24104479
Pubmed	STIM1, but not STIM2, is required for proper agonist-induced Ca2+ signaling.	ITPR1 STIM1	1.00e-04	3	202	2	20801505
Pubmed	The fragile X mental retardation syndrome protein interacts with novel homologs FXR1 and FXR2.	FXR2 FXR1	1.00e-04	3	202	2	7489725
Pubmed	Specific sequences in the fragile X syndrome protein FMR1 and the FXR proteins mediate their binding to 60S ribosomal subunits and the interactions among them.	FXR2 FXR1	1.00e-04	3	202	2	8668200
Pubmed	Association of c3 gene polymorphisms with neovascular age-related macular degeneration in a chinese population.	CFB C3	1.00e-04	3	202	2	19899988
Pubmed	Structural basis for the substrate specificity of bone morphogenetic protein 1/tolloid-like metalloproteases.	TLL1 TLL2	1.00e-04	3	202	2	18824173
Pubmed	Epigenetic silencing of heat shock protein 70 through DNA hypermethylation in pseudoexfoliation syndrome and glaucoma.	HSPA4 DNMT3A	1.00e-04	3	202	2	32127624
Pubmed	A conditional Smg6 mutant mouse model reveals circadian clock regulation through the nonsense-mediated mRNA decay pathway.	PER2 ALB	1.00e-04	3	202	2	36638184
Pubmed	Association of genetic variants rs641153 (CFB), rs2230199 (C3), and rs1410996 (CFH) with age-related macular degeneration in a Brazilian population.	CFB C3	1.00e-04	3	202	2	34233521
Pubmed	Variation in complement factor 3 is associated with risk of age-related macular degeneration.	CFB C3	1.00e-04	3	202	2	17767156
Pubmed	Structural basis for the stabilization of the complement alternative pathway C3 convertase by properdin.	CFB C3	1.00e-04	3	202	2	23901101
Pubmed	LLPS of FXR proteins drives replication organelle clustering for β-coronaviral proliferation.	FXR2 FXR1	1.00e-04	3	202	2	38587486
Pubmed	Inherited Kidney Complement Diseases.	CFB C3	1.00e-04	3	202	2	33536243
Pubmed	Endophilin A2-mediated alleviation of endoplasmic reticulum stress-induced cardiac injury involves the suppression of ERO1α/IP3R signaling pathway.	ITPR1 ERO1A	1.00e-04	3	202	2	34512174
Interaction	SYNE3 interactions	PEX1 CEP128 STIM1 ZCCHC14 PLEKHG1 ALMS1 BRCA2 ANAPC1 NUP210 OBI1 CEP97 NOTCH2 ERO1A GPATCH1 STIL MOXD1 NUP155 CEP152 CRYBG3 TOR1AIP1 NIN	3.36e-09	444	199	21	int:SYNE3
Interaction	PHF21A interactions	RREB1 HMG20A ALMS1 BRCA2 ANAPC1 CHD6 MGA OBI1 CASP8AP2 NELFCD RUFY1 RLF ZFHX3 CRYBG3 PCCA	1.72e-06	343	199	15	int:PHF21A
Interaction	TNRC6B interactions	CEP128 ALMS1 ATXN2 GLI2 OBI1 CEP97 FXR2 APBA3 STIL FXR1 NUP155 CEP152 NIN	4.87e-06	282	199	13	int:TNRC6B
Interaction	ALMS1 interactions	CEP128 ALMS1 HSPA4 CEP97 OC90 STIL YWHAG NUP155 CEP152 NIN	5.52e-06	164	199	10	int:ALMS1
Interaction	RCOR1 interactions	SPTAN1 RREB1 DNAJC6 HMG20A ALMS1 BRCA2 ANAPC1 CHD6 MGA HSPA4 OBI1 CASP8AP2 NELFCD RUFY1 RLF ZFHX3 PCCA	8.77e-06	494	199	17	int:RCOR1
Interaction	AMOT interactions	WASHC2A CEP128 PLEKHG1 ALMS1 KDF1 OBI1 CEP97 WASHC2C RUFY1 YWHAG CEP152 CRYBG3 NIN	1.44e-05	312	199	13	int:AMOT
Interaction	CEP135 interactions	CEP128 PLEKHG1 ALMS1 BRCA2 CEP97 WASHC2C GPATCH1 STIL NUP155 CEP152 TOR1AIP1 NIN	1.76e-05	272	199	12	int:CEP135
Interaction	DDX19B interactions	AHI1 GNG8 ATXN7L1 MIF4GD CFB C3 ARMC6 APBA3 YWHAG NUP155 LRP1	4.21e-05	251	199	11	int:DDX19B
GeneFamily	Zinc fingers C2H2-type\|ZF class homeoboxes and pseudogenes	ZNF597 ZNF777 PEG3 ZKSCAN7 RREB1 ZNF320 GLI2 ZNF655 ZNF283 ZNF860 ZNF484 ZNF772 RLF ZNF28 ZFHX3 PRDM15 ZNF121	2.31e-05	718	134	17	28
GeneFamily	Bone morphogenetic proteins\|Astacins	TLL1 TLL2	8.02e-04	6	134	2	894
GeneFamily	WASH complex	WASHC2A WASHC2C	8.02e-04	6	134	2	1331
Coexpression	CYCLIN_D1_UP.V1_DN	MYH2 CUL7 CFB PTPN4 BRCA2 COG2 FXR2 GUCY1A2 EML1	1.70e-05	190	201	9	M2652
Coexpression	PYEON_CANCER_HEAD_AND_NECK_VS_CERVICAL_UP	MYO5C SYCP2 ATAD2B NUP210 CASP8AP2 CASK TMPO CEP152 PRDM15	2.09e-05	195	201	9	M13736
Coexpression	GSE22886_IGG_IGA_MEMORY_BCELL_VS_BLOOD_PLASMA_CELL_UP	SPTAN1 ITGA9 SYCP2 OBI1 NOTCH2 COL6A3 NTRK2 RSBN1 OGA	2.46e-05	199	201	9	M4444
Coexpression	GSE40274_FOXP3_VS_FOXP3_AND_GATA1_TRANSDUCED_ACTIVATED_CD4_TCELL_DN	SPTAN1 ATXN2 XPO6 KIT DNMT3A FXR2 IFI44 TEX15 ABCG1	2.46e-05	199	201	9	M9180
CoexpressionAtlas	FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_1000_k-means-cluster#3	EPC2 AHI1 CHD2 ITGB8 ALMS1 ATAD2B HSPA4 CASP8AP2 CWC22 CREB5 EXOC5 FMN2	9.66e-06	271	198	12	Facebase_RNAseq_e10.5_Mandibular Arch_1000_K3
ToppCell	NS-moderate-d_07-13-Epithelial-FOXN4+\|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	CEP128 ALMS1 BRCA2 ZMYND10 FAM149A DOC2A KIF27 STIL ZBBX CEP152 CCDC171 HYDIN	8.32e-12	157	202	12	410c9d74a2085179cfb39853cb6d330fa98c9c1b
ToppCell	TCGA-Ovary-Primary_Tumor-Ovarian_Carcinoma-Serous_Cystadenocarcinoma-5\|TCGA-Ovary / Sample_Type by Project: Shred V9	OBSCN ANKMY1 CHD2 PTPN4 MGA PMS2 HECTD4 USP40 OGA	7.14e-08	166	202	9	32d2eaf8a5d03881bf74d680825af2d5110b082d
ToppCell	moderate-Epithelial-FOXN4+\|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	AHI1 MYO5C SYCP2 ALMS1 BRCA2 ZMYND10 STIL CEP152 CCDC171	2.69e-07	194	202	9	5dffa578149104dda33774361e9e77b227b5f1ce
ToppCell	5'-Adult-Appendix-Mesenchymal-fibroblastic-Stromal_1_(CCL11+)\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	OBSCN GGT5 PCDH11X COL6A3 TRPA1 ADAMTS1 SLC9A5 CRYBG3	1.35e-06	174	202	8	f90ca117b729436cf452e2ddcec26ba525c5c13b
ToppCell	kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	GGT5 GLI2 C3 NOTCH2 COL6A3 MOXD1 GUCY1A2 LRP1	1.35e-06	174	202	8	9c916af5eebd932f67dc9117e1d26ff194a2ff2c
ToppCell	kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	GGT5 GLI2 C3 NOTCH2 COL6A3 MOXD1 GUCY1A2 LRP1	1.35e-06	174	202	8	bc71521f44a5fe013af42b06b5d1bd2446ecf3b5
ToppCell	368C-Myeloid-Macrophage-SPP1+_Macrophage_3\|368C / Donor, Lineage, Cell class and subclass (all cells)	CUL7 ZNF320 ALMS1 XPO6 KCNJ5-AS1 C2orf42 SIGLEC11 PRDM15	1.60e-06	178	202	8	536a601abcc60867949ea06e9aafb6c7b799b56b
ToppCell	kidney_cells-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	GGT5 ZNF860 RGPD2 COL6A3 ZNF484 ADAMTS1 MOXD1 GUCY1A2	2.13e-06	185	202	8	e1fbec55b71f604189eb2431768fadbaa0453a83
ToppCell	kidney_cells-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	GGT5 ZNF860 RGPD2 COL6A3 ZNF484 ADAMTS1 MOXD1 GUCY1A2	2.13e-06	185	202	8	9d933cd5ebc8368fd37aa83113d2dfa6938ff72d
ToppCell	NS-moderate-d_16-33-Epithelial-FOXN4+\|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	CEP128 SYCP2 ALMS1 BRCA2 STIL CEP152 EML1 CCDC171	2.59e-06	190	202	8	250ca4a605c1cccd77d23383e4fe6f91cf3609ba
ToppCell	LPS-IL1RA+antiTNF-Stromal_mesenchymal\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	GLI2 CCDC3 COL6A3 ADAMTS1 MOXD1 GUCY1A2 LRP1 MYO16	2.80e-06	192	202	8	3d0cb19f037f604253d7d728689aeaa94251e92b
ToppCell	facs-Aorta-Heart-3m\|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PEG3 ITGA9 TM9SF2 SERINC3 ALB IFI44 ZFHX3 HYDIN	2.80e-06	192	202	8	1ccc47792edf9ee23501c8e2165d11271636b66a
ToppCell	LPS-antiTNF-Stromal_mesenchymal\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	GLI2 CCDC3 COL6A3 ADAMTS1 MOXD1 GUCY1A2 LRP1 MYO16	3.03e-06	194	202	8	6e13549f697f7478b34fe71f7dd9d63c5d3db22e
ToppCell	moderate-Epithelial-FOXN4+\|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	AHI1 CEP128 SYCP2 ALMS1 BRCA2 STIL CEP152 CCDC171	3.03e-06	194	202	8	dff3fb10372053951d41e0ccd41aac3ece6009bd
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	GGT5 GLI2 CCDC3 C3 COL6A3 MOXD1 GUCY1A2 LRP1	3.15e-06	195	202	8	3c3703f092b6fc1b7333426fb5e2823bfb74bb57
ToppCell	Control_saline-Epithelial_airway-airway_epithelial-Ciliated\|Control_saline / Treatment groups by lineage, cell group, cell type	ANKMY1 ZMYND10 KIF27 ZBBX LRRC9 CFAP52 CFAP61 HYDIN	3.15e-06	195	202	8	60067b5359174f0d1a8b5748bfc0690762e9e740
ToppCell	Brain_organoid-organoid_Paulsen_bioRxiv-3.5_mon-Proliferating-Cycling_Progenitors\|3.5_mon / Sample Type, Dataset, Time_group, and Cell type.	ITGB8 BRCA2 NOTCH2 STIL MOXD1 SHCBP1 TMPO CEP152	3.27e-06	196	202	8	5905f0e3061a6b98b7a33d64c782c3dda2cd51ef
ToppCell	Control_saline-Epithelial_airway\|Control_saline / Treatment groups by lineage, cell group, cell type	ANKMY1 CAPN13 ZMYND10 C3 ALB ZBBX CFAP61 HYDIN	3.52e-06	198	202	8	e6863238e022ecfb6a8e3f4b7661b376e92c5d8f
ToppCell	Control_saline-Epithelial_airway-airway_epithelial\|Control_saline / Treatment groups by lineage, cell group, cell type	ANKMY1 CAPN13 ZMYND10 C3 ALB ZBBX CFAP61 HYDIN	3.52e-06	198	202	8	e7aa42e5fbd42c68f50cda4a8f3aa464c862c007
ToppCell	LPS_IL1RA_TNF-Epithelial_airway-airway_epithelial\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	ANKMY1 CAPN13 ZMYND10 ALB ZBBX LRRC9 CFAP52 HYDIN	3.79e-06	200	202	8	da12821e8a0657869ca0f75d351cce2d7605a505
ToppCell	LPS_IL1RA_TNF-Epithelial_airway\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	ANKMY1 CAPN13 ZMYND10 ALB ZBBX LRRC9 CFAP52 HYDIN	3.79e-06	200	202	8	72c1d9eeaed4b3ee6b6c602e8aa29efc2e8744eb
ToppCell	LPS-antiTNF-Epithelial_airway-Ciliated_cells-Ciliated\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ANKMY1 ZMYND10 ZBBX LRRC9 CFAP52 CFAP61 HYDIN	5.19e-06	148	202	7	d61123f0c811287843d066b932b4a9ff09c07c5b
ToppCell	LPS-antiTNF-Epithelial_airway-Ciliated_cells\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ANKMY1 ZMYND10 ZBBX LRRC9 CFAP52 CFAP61 HYDIN	5.19e-06	148	202	7	c8e93b87212f55774223caa385859c566fa1981f
ToppCell	5'-Parenchyma_lung-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.2.0\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	PEG3 SYCP2 ALMS1 ZMYND10 DOC2A SIGLEC11 HYDIN	6.74e-06	154	202	7	ec56b7fb88e39041416c384f371c767f3b4e92fa
ToppCell	Control-Epithelial_airway-Ciliated_cells-Ciliated\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ANKMY1 ZMYND10 ZBBX LRRC9 CFAP52 CFAP61 HYDIN	6.74e-06	154	202	7	4e3bc24043144143842627cacf6f90dda2228910
ToppCell	Control-Epithelial_airway-Ciliated_cells\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ANKMY1 ZMYND10 ZBBX LRRC9 CFAP52 CFAP61 HYDIN	6.74e-06	154	202	7	7556a4b2b062da5ae7ec2bbb66e745e7662db628
ToppCell	LPS-IL1RA+antiTNF-Epithelial_airway-Ciliated_cells\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ZMYND10 ZBBX LRRC9 CFAP52 ANKEF1 CFAP61 HYDIN	7.03e-06	155	202	7	5f1e2195a6b831e1b636f5cc3a282ca423721822
ToppCell	LPS-IL1RA+antiTNF-Epithelial_airway-Ciliated_cells-Ciliated\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ZMYND10 ZBBX LRRC9 CFAP52 ANKEF1 CFAP61 HYDIN	7.03e-06	155	202	7	0944429459f642a1bcc56edc1ec28aaecde3e2dc
ToppCell	367C-Lymphocytic-NK_cells-NK_cell_D2\|NK_cells / Donor, Lineage, Cell class and subclass (all cells)	ZCCHC14 PLEKHG1 CREB5 C1GALT1C1 USP40 SSBP4 ANKS3	7.33e-06	156	202	7	0b3630fd4479291599e1674e87eba6f93877ac3a
ToppCell	356C-Fibroblasts-Fibroblast-D\|356C / Donor, Lineage, Cell class and subclass (all cells)	ZKSCAN7 CCDC168 GGT5 NTRK2 BEND2 MOXD1 GUCY1A2	1.10e-05	166	202	7	7286a37b2827f3747469ffd0d76cbe81116db7ee
ToppCell	356C-Fibroblasts-Fibroblast-D-\|356C / Donor, Lineage, Cell class and subclass (all cells)	ZKSCAN7 CCDC168 GGT5 NTRK2 BEND2 MOXD1 GUCY1A2	1.10e-05	166	202	7	7c2eee0a4f45795a956acf936b85bdb35f1b1624
ToppCell	facs-Heart-RV-18m-Mesenchymal\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CFB ALMS1 CCDC3 C3 COL6A3 NTRK2 LRP1	1.28e-05	170	202	7	d7c9a604311974ff87ece43a0f8725a234d262f7
ToppCell	normal-na-Lymphocytic_B-B_plasma-male\|normal / PBMC cell types (v2) per disease, treatment status, and sex	CEP128 BRCA2 ZC2HC1B MOXD1 ANKEF1 DENND2C PCCA	1.28e-05	170	202	7	c5b87974dfddf9780051f7f5693eeeb0c606a3fe
ToppCell	IIH-CD8-naive_CD4\|IIH / Condition, Cell_class and T cell subcluster	OBSCN MRPS27 ZNF280B ANKMY1 UTP20 ARMC6 GPATCH1	1.44e-05	173	202	7	4f2843371d18af766c1892529ce286f56c956fde
ToppCell	facs-Heart-RV-18m-Mesenchymal-fibroblast_of_cardiac_tissue\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CFB ALMS1 CCDC3 C3 COL6A3 NTRK2 LRP1	1.61e-05	176	202	7	c0a084f7a8645262d61971f094689e02bf15b113
ToppCell	facs-Heart-RV-18m-Mesenchymal-fibroblast_of_cardiac_tissue\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CFB ALMS1 CCDC3 C3 COL6A3 NTRK2 LRP1	1.61e-05	176	202	7	cccf9201f6e2da7524b911a5961d3b227edab222
ToppCell	5'-Airway_Nasal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Deuterosomal\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	ALMS1 BRCA2 ZMYND10 CEP97 STIL CEP152 CCDC171	1.79e-05	179	202	7	d15182c668d7c37be8214cad9f1fe35d1409c9a1
ToppCell	5'-Airway_Nasal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Deuterosomal-Deuterosomal_L.0.3.4.0\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	ALMS1 BRCA2 ZMYND10 CEP97 STIL CEP152 CCDC171	1.79e-05	179	202	7	e22a275a7c0ed19113c833a75d6c49fcc19aa13a
ToppCell	Ciliated_cells-B-Donor_06\|World / lung cells shred on cell class, cell subclass, sample id	ZMYND10 DOC2A MAPK8IP1 ZBBX CFAP52 FMN2 HYDIN	1.86e-05	180	202	7	bdea5ec6b60fc8c7cce4d71db5da74ac8675e211
ToppCell	kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	GGT5 PTPRH GLI2 COL6A3 MOXD1 GUCY1A2 LRP1	1.92e-05	181	202	7	c6d2a13df3b74fade3b0c71e285b4c14c8e52413
ToppCell	kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	GGT5 PTPRH GLI2 COL6A3 MOXD1 GUCY1A2 LRP1	1.92e-05	181	202	7	c62b0a2422377ffadaab63edd538e87a06fa5017
ToppCell	390C-Lymphocytic-CD4_T-cell-Treg_cell_2\|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells)	NBPF12 PLEKHG1 FBXO9 CEP97 RGPD2 HECTD4 PCCA	1.99e-05	182	202	7	21744c9c792e57d5d41b25986f419b2358c7057b
ToppCell	COVID-19-kidney-Mito-rich_EC\|kidney / Disease (COVID-19 only), tissue and cell type	INPP5D ITGA9 PLEKHG1 IFI44 ABCG1 TLL1 EML1	2.07e-05	183	202	7	3c4153479fc4ab2d073d92cee120480015555914
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	OBSCN SYCP2 PCDH11X STAB2 LOXHD1 HYDIN MYO16	2.14e-05	184	202	7	2cbed6462fea2622871bb7e49b0df3d984239281
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	GGT5 GLI2 COL6A3 BEND2 MOXD1 GUCY1A2 LRP1	2.14e-05	184	202	7	e061e85c4bb19f49f6451ddd7a9077d7378ee365
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	OBSCN SYCP2 PCDH11X STAB2 LOXHD1 HYDIN MYO16	2.14e-05	184	202	7	ea7a7e2bac46d4d2c31a5d576b38a032b5335062
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	OBSCN SYCP2 PCDH11X STAB2 LOXHD1 HYDIN MYO16	2.14e-05	184	202	7	2b19a8c5f823e00812908b23e66bb4e563278aff
ToppCell	Children_(3_yrs)-Epithelial-ciliated_cell-D139\|Children_(3_yrs) / Lineage, Cell type, age group and donor	ZMYND10 DOC2A ZBBX CFAP52 FMN2 CFAP61 HYDIN	2.14e-05	184	202	7	5daff849625f2f41d56615569c0ed59cd733b34c
ToppCell	15-Trachea-Epithelial-Multiciliated_precursor\|Trachea / Age, Tissue, Lineage and Cell class	AHI1 CEP128 MYO5C ZMYND10 STIL CEP152 CCDC171	2.22e-05	185	202	7	9a8b8360d99375b726ca8e3c9a3f9b08919892d7
ToppCell	Adult-Epithelial-ciliated_cell-D175\|Adult / Lineage, Cell type, age group and donor	ZMYND10 DOC2A ZBBX CFAP52 FMN2 CFAP61 HYDIN	2.22e-05	185	202	7	30f4980dee6cd5959655f8d74049f3bfb5312611
ToppCell	human_hepatoblastoma-Hepatic_Stellate_cells\|World / Sample and Cell Type and Tumor Cluster (all cells)	ITPR1 GLI2 CCDC3 COL6A3 ADAMTS1 CREB5 GUCY1A2	2.29e-05	186	202	7	cb1fc4b9140666b43415e21c9b434dc9b144e9d0
ToppCell	Epithelial-ciliated_cell\|World / Lineage, Cell type, age group and donor	ZMYND10 DOC2A ZBBX CFAP52 FMN2 CFAP61 HYDIN	2.46e-05	188	202	7	61a459f3fe57e5728efc72637ff2edc2d343492b
ToppCell	Children_(3_yrs)-Epithelial-ciliated_cell\|Children_(3_yrs) / Lineage, Cell type, age group and donor	ZMYND10 DOC2A ZBBX CFAP52 FMN2 CFAP61 HYDIN	2.46e-05	188	202	7	2b6dfc88be9ded7b88da9fe78a9cd9f9b3af8af3
ToppCell	Children_(3_yrs)-Epithelial-ciliated_cell-D032\|Children_(3_yrs) / Lineage, Cell type, age group and donor	ZMYND10 DOC2A ZBBX CFAP52 FMN2 CFAP61 HYDIN	2.54e-05	189	202	7	68a3cf7763d6f9b95d6d6524eff7a16042703f1d
ToppCell	LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	GLI2 CCDC3 COL6A3 MOXD1 GUCY1A2 LRP1 MYO16	2.54e-05	189	202	7	a153b83314cf52808f685296cff8c95af3f4983d
ToppCell	LPS_only-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	GLI2 CCDC3 COL6A3 MOXD1 GUCY1A2 LRP1 MYO16	2.54e-05	189	202	7	2a22b9fae70afb3dab8476f9c00e48a4df756410
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	GGT5 GLI2 COL6A3 MOXD1 LOXHD1 GUCY1A2 LRP1	2.63e-05	190	202	7	2306aa9dbeaef3be8484a5b236605de23cd75d4c
ToppCell	LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ITGB8 GLI2 CCDC3 COL6A3 GUCY1A2 LRP1 MYO16	2.63e-05	190	202	7	45df8fee00f8949937863159d7aa042e72748d9b
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	GGT5 GLI2 COL6A3 MOXD1 LOXHD1 GUCY1A2 LRP1	2.63e-05	190	202	7	1f83f7f24288a3b9ab33c2e113e845dba96adc8a
ToppCell	LPS_only-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	PEG3 GLI2 CCDC3 COL6A3 MOXD1 LRP1 MYO16	2.63e-05	190	202	7	d60395739458d7f47a3350ade751fe3819500320
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	GGT5 GLI2 COL6A3 MOXD1 LOXHD1 GUCY1A2 LRP1	2.72e-05	191	202	7	a58c75e9580139fb370b498d95660f10f3a2a27b
ToppCell	LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	GLI2 CCDC3 COL6A3 MOXD1 GUCY1A2 LRP1 MYO16	2.72e-05	191	202	7	b13229bb7f3713a392271aaf5dbae3edd1b9fe5a
ToppCell	Control-Stromal_mesenchymal\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	PEG3 ITGA9 GLI2 CCDC3 NOTCH2 LRP1 MYO16	2.72e-05	191	202	7	14057205ddb9b4bbc582d1358d13cf36d979a61b
ToppCell	COVID-19-kidney-Proliferating_T_cell\|COVID-19 / Disease (COVID-19 only), tissue and cell type	CEP128 BRCA2 NUP210 STIL SHCBP1 TMPO CEP152	2.72e-05	191	202	7	bae388e0e9447d576e68465d73d8313ef6925ffa
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	ITGA9 GGT5 GLI2 COL6A3 MOXD1 GUCY1A2 LRP1	2.72e-05	191	202	7	39092a0aff8097617820c59f5fea9ee2bb4f63a2
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	ITGA9 GGT5 GLI2 COL6A3 MOXD1 GUCY1A2 LRP1	2.72e-05	191	202	7	ee5f1b1c59029c46cbb1a00935c03b9317bb9da9
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	GGT5 GLI2 COL6A3 MOXD1 LOXHD1 GUCY1A2 LRP1	2.81e-05	192	202	7	9093a9e94a25682d109a7f6edc256a25a61103a0
ToppCell	LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	GLI2 CCDC3 COL6A3 MOXD1 GUCY1A2 LRP1 MYO16	2.81e-05	192	202	7	6f4ef24dab544681304b7f8a9dc073e7edaa4cf5
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	ITGA9 GGT5 GLI2 COL6A3 MOXD1 GUCY1A2 LRP1	2.81e-05	192	202	7	bc84b9ce01b4d826a682842ab8a395dac9b91183
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	GGT5 GLI2 COL6A3 MOXD1 LOXHD1 GUCY1A2 LRP1	2.81e-05	192	202	7	9ed5d49621ec1aa01716dc369bba1450b5f015f5
ToppCell	LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	GLI2 CCDC3 COL6A3 MOXD1 GUCY1A2 LRP1 MYO16	2.81e-05	192	202	7	dcd924d6eb67d33ee9f5d3e8ab6e1d4283d6b708
ToppCell	LPS-IL1RA-Stromal_mesenchymal\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	GLI2 CCDC3 COL6A3 MOXD1 GUCY1A2 LRP1 MYO16	2.81e-05	192	202	7	4e47a02007f562f29ba5910df64d32a0167d0bd1
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	ITGA9 GGT5 GLI2 COL6A3 MOXD1 GUCY1A2 LRP1	2.81e-05	192	202	7	0ab1176cfbb0de8dd1f22c6e2c41265cf6c10ee1
ToppCell	LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	GLI2 CCDC3 COL6A3 MOXD1 GUCY1A2 LRP1 MYO16	2.81e-05	192	202	7	deeecd26972241846b4cb998edf0c7a87ff0c4df
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	GGT5 GLI2 COL6A3 MOXD1 LOXHD1 GUCY1A2 LRP1	2.90e-05	193	202	7	f1199518c3626fd29bfce65070dd21a660671213
ToppCell	LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	GLI2 CCDC3 COL6A3 MOXD1 GUCY1A2 LRP1 MYO16	2.90e-05	193	202	7	fb28717fadd06c3840636d25409ce80c9254bd34
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	GGT5 GLI2 CCDC3 C3 COL6A3 GUCY1A2 LRP1	3.00e-05	194	202	7	c49f72441b3557e2c3a9c4239e68c0cf0652814b
ToppCell	LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	GLI2 CCDC3 COL6A3 MOXD1 GUCY1A2 LRP1 MYO16	3.00e-05	194	202	7	60622bd2f75bfe4c37f721cb12f03dab33f2f58d
ToppCell	LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	GLI2 CCDC3 COL6A3 MOXD1 GUCY1A2 LRP1 MYO16	3.00e-05	194	202	7	89b706af2b25991fc2707eb24f49ba6ff3ae01f7
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	GGT5 GLI2 CCDC3 COL6A3 MOXD1 GUCY1A2 LRP1	3.10e-05	195	202	7	49c99553629cdd83ee56a2e508d5bc8d34b8507b
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	GGT5 GLI2 CCDC3 COL6A3 MOXD1 GUCY1A2 LRP1	3.10e-05	195	202	7	dd281a249854800f737dc22e0f375f66dfb5cf5f
ToppCell	COVID-19-T_cells-Cycling_NK/T_cells\|COVID-19 / group, cell type (main and fine annotations)	CEP128 BRCA2 NUP210 STIL SHCBP1 TMPO CEP152	3.10e-05	195	202	7	764ed100c28d9bc93ee5ecabc5291c8f184d78da
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	GGT5 GLI2 CCDC3 COL6A3 MOXD1 GUCY1A2 LRP1	3.10e-05	195	202	7	edd4cd8402af81737b2074f9dce71cc6ab09be7e
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	GGT5 GLI2 COL6A3 MOXD1 LOXHD1 GUCY1A2 LRP1	3.10e-05	195	202	7	44d7bef5f59c2c2bad1392ee6aabdaa5d7f531d9
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	GGT5 GLI2 COL6A3 MOXD1 LOXHD1 GUCY1A2 LRP1	3.20e-05	196	202	7	a12dd986df65c36f248cf10815c3b8b6238613b0
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	GGT5 GLI2 COL6A3 MOXD1 LOXHD1 GUCY1A2 LRP1	3.20e-05	196	202	7	ba869f7a86f37fd6d84d6ad69baca0e0faaf5887
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	GGT5 GLI2 COL6A3 MOXD1 LOXHD1 GUCY1A2 LRP1	3.20e-05	196	202	7	30ad56d49000e4ddce73b4443b3994564bd1e2d6
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	GGT5 GLI2 COL6A3 MOXD1 LOXHD1 GUCY1A2 LRP1	3.20e-05	196	202	7	3e6803587d8566fd08cb8b290be3b6461743d79c
ToppCell	facs-Trachea-3m\|Trachea / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	MBTPS1 PEG3 TM9SF2 SERINC3 NOTCH2 COL6A3 SAR1A	3.31e-05	197	202	7	e77016d64b1cac9825fec7cfe5071f1567401187
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	GGT5 GLI2 COL6A3 MOXD1 LOXHD1 GUCY1A2 LRP1	3.31e-05	197	202	7	6d027119a5f7ca2aac1b10837e43f9a2bb54db85
ToppCell	facs-Brain_Myeloid-Cortex_-18m-Myeloid-nan\|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	INPP5D RCBTB2 TM9SF2 SERINC3 COL6A3 CASK ZFHX3	3.31e-05	197	202	7	e73ca8c8f42cbcc56eaa5fe3d69abd1ce7b7bbca
ToppCell	facs-Brain_Myeloid-Cortex_\|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	INPP5D RCBTB2 TM9SF2 SERINC3 COL6A3 CASK ZFHX3	3.31e-05	197	202	7	81379fe6bd14a1ba26f4a159497262adcb600b18
ToppCell	facs-Brain_Myeloid-Cortex_-18m\|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	INPP5D RCBTB2 TM9SF2 SERINC3 COL6A3 CASK ZFHX3	3.31e-05	197	202	7	271c75f491d03bd248c7ec037ef02e39456f3ac0
ToppCell	facs-Brain_Myeloid-Cortex_-18m-Myeloid\|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	INPP5D RCBTB2 TM9SF2 SERINC3 COL6A3 CASK ZFHX3	3.31e-05	197	202	7	9db329c6fea532dd1afb624f4c29c92407f45568
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	GGT5 GLI2 COL6A3 MOXD1 LOXHD1 GUCY1A2 LRP1	3.31e-05	197	202	7	b349f8e96d61a4c296af64711e11fc44459a9413
ToppCell	facs-Brain_Myeloid-Cortex_-18m-Myeloid-microglial_cell\|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	INPP5D RCBTB2 TM9SF2 SERINC3 COL6A3 CASK ZFHX3	3.31e-05	197	202	7	173c0c8de4e69882a9f91189deeb4a651fefe551
ToppCell	Tracheal-10x5prime-Epithelial-Epi_airway_ciliated-Deuterosomal\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	ZMYND10 NGEF ALB DOC2A STIL ZBBX HYDIN	3.31e-05	197	202	7	6e4a411ef823ce9e16f420e185e21fa19d13af34
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	GGT5 GLI2 COL6A3 MOXD1 LOXHD1 GUCY1A2 LRP1	3.31e-05	197	202	7	c2e390653d5dee7e731c1840cfdab41987dede9b
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	INPP5D ITGA9 PLEKHG1 CCDC3 PCDH11X IFI44 TLL1	3.42e-05	198	202	7	b027a141ab531d0f5d6a26811a53427e7b0771dd
ToppCell	Primary_Visual_cortex_(V1C)-Neuronal\|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	AHI1 SPTAN1 PEG3 ITPR1 PCDH11X NTRK2 FMN2	3.42e-05	198	202	7	8ab40fae14fe02e39bc8c8da187a5cd60c787643
Disease	carbohydrate intake measurement	ATXN2 FTO HECTD4 ZFHX3 CCDC171	2.64e-06	34	192	5	EFO_0010811
Disease	factor VIII measurement, Ischemic stroke	ATXN2 STAB2 STXBP5 HECTD4	6.24e-06	19	192	4	EFO_0004630, HP_0002140
Disease	reaction time measurement	DOK6 ATXN2 ATAD2B CCDC3 NGEF CHD6 OC90 GCFC2 KIF27 HECTD4 MSH3 FXR1 KANSL1 ZFHX3 CCDC171 RAI1	7.12e-06	658	192	16	EFO_0008393
Disease	anthropometric measurement	ITGB8 PER2 ATXN2 CCDC3 FTO DNMT3A LRIG3 CCDC171	1.52e-05	168	192	8	EFO_0004302
Disease	systemic lupus erythematosus	AHI1 CFB MYO5C HMG20A STIM1 TM9SF2 PTPRH ATXN2 C2orf42 C3 KIT NOTCH2 COL6A3 HECTD4 CWC22 RSBN1 SSBP4	2.06e-05	799	192	17	MONDO_0007915
Disease	Malignant neoplasm of breast	SPTAN1 OBSCN ITGA9 ZCCHC14 PER2 BRCA2 UTP20 FTO KIT NOTCH2 DNMT3A ADAMTS1 RUFY1 PPP1R3A FXR1 LLGL1 GUCY1A2 TLL1 ANKEF1 TOR1AIP1	2.57e-05	1074	192	20	C0006142
Disease	severe acute respiratory syndrome, COVID-19	INPP5D PTPN4 GLI2 NUP210 PCDH11X COL6A3 PMS2 TRPC7 NTRK2 CREB5 CASK ZFHX3	4.00e-05	447	192	12	EFO_0000694, MONDO_0100096
Disease	Ischemic stroke, von Willebrand factor measurement	ATXN2 STAB2 STXBP5 HECTD4	4.17e-05	30	192	4	EFO_0004629, HP_0002140
Disease	erythema nodosum (is_marker_for)	CFB C3	4.21e-05	2	192	2	DOID:0080750 (is_marker_for)
Disease	boutonneuse fever (is_marker_for)	CFB C3	4.21e-05	2	192	2	DOID:14095 (is_marker_for)
Disease	anterior uveitis (is_marker_for)	CFB C3	4.21e-05	2	192	2	DOID:1407 (is_marker_for)
Disease	conjunctivitis (is_marker_for)	CFB C3	4.21e-05	2	192	2	DOID:6195 (is_marker_for)
Disease	Hemolytic-Uremic Syndrome	CFB C3 ALB	4.31e-05	11	192	3	C0019061
Disease	obesity (implicated_via_orthology)	GNG8 ETV5 ITPR1 STIM1 ALMS1 C3 NOTCH2 ZFHX3	8.76e-05	215	192	8	DOID:9970 (implicated_via_orthology)
Disease	Ischemic stroke, tissue plasminogen activator measurement	ATXN2 STXBP5 HECTD4	1.16e-04	15	192	3	EFO_0004791, HP_0002140
Disease	Addicted to cocaine	PER2 GRM2	1.26e-04	3	192	2	C0858355
Disease	fragile X syndrome (implicated_via_orthology)	FXR2 FXR1	1.26e-04	3	192	2	DOID:14261 (implicated_via_orthology)
Disease	complement C3D fragment measurement	CFB C3	1.26e-04	3	192	2	EFO_0020277
Disease	malignant pleural mesothelioma (implicated_via_orthology)	FXR2 FXR1	1.26e-04	3	192	2	DOID:7474 (implicated_via_orthology)
Disease	bilirubin measurement	INPP5D RREB1 ATXN2 GLI2 NGEF ALB ABCC2 ARMC6 TLL1 USP40 CCDC171	1.63e-04	442	192	11	EFO_0004570
Disease	factor VIII deficiency (is_marker_for)	CFB C3	2.51e-04	4	192	2	DOID:12134 (is_marker_for)
Disease	Flushing	ATXN2 HECTD4	2.51e-04	4	192	2	HP_0031284
Disease	response to steroid, systemic lupus erythematosus, idiopathic osteonecrosis of the femoral head	RREB1 MYO16	2.51e-04	4	192	2	EFO_0020976, EFO_1001930, MONDO_0007915
Disease	lepromatous leprosy (is_marker_for)	CFB C3	2.51e-04	4	192	2	DOID:10887 (is_marker_for)
Disease	pulse pressure measurement	EPC2 MRPS27 CHD2 RREB1 ITGA9 CFB PLEKHG1 ATAD2B FTO OBI1 CEP97 COL6A3 CWC22 CREB5 LRIG3 KANSL1 LRP1 ZFHX3 EML1 HYDIN NIN	3.08e-04	1392	192	21	EFO_0005763
Disease	monocyte count	ZNF777 AHI1 INPP5D RREB1 GGT5 ZNF320 PTPRH ATXN2 XPO6 C3 KIT HSPA4 STAB2 FXR2 STXBP5 CREB5 RSBN1 SSBP4 MYO16 RAI1	4.07e-04	1320	192	20	EFO_0005091
Disease	cholestasis (is_marker_for)	ALB ABCC2	4.16e-04	5	192	2	DOID:13580 (is_marker_for)
Disease	nasopharyngeal neoplasm	ITGA9 R3HCC1L NTRK2 CREB5 ZFHX3 RHOT1	4.79e-04	151	192	6	EFO_0004252
Disease	autism spectrum disorder (implicated_via_orthology)	ZNF280B CHD2 CHD6 FXR2 CASK FXR1	4.96e-04	152	192	6	DOID:0060041 (implicated_via_orthology)
Disease	Neoplasm of the genitourinary tract	BRCA2 KIT ZFHX3	4.96e-04	24	192	3	cv:C0042065
Disease	multiple sclerosis	AHI1 RREB1 ITPR1 TM9SF2 ATXN2 SYDE2 DNMT3A GTDC1 YWHAG KANSL1 TLL1 ZFHX3	5.51e-04	594	192	12	MONDO_0005301
Disease	atrophic macular degeneration	CFB C3 TEX15	5.61e-04	25	192	3	EFO_1001492
Disease	lymphocyte count	RREB1 ITPR1 GGT5 PTPN4 TM9SF2 ALMS1 PTPRH ZMYND10 ATXN2 ANAPC1 XPO6 ATAD2B C3 OBI1 NOTCH2 DNMT3A KIF27 HECTD4 IFI44 RSBN1 RAI1	5.95e-04	1464	192	21	EFO_0004587
Disease	Idiopathic Membranous Glomerulonephritis	C3 ALB	6.21e-04	6	192	2	C0086445
Disease	Heymann Nephritis	C3 ALB	6.21e-04	6	192	2	C1704378
Disease	Membranous glomerulonephritis	C3 ALB	6.21e-04	6	192	2	C0017665
Disease	Diabetes Mellitus, Non-Insulin-Dependent	EPC2 HMG20A C3 FTO NOTCH2 MAPK8IP1 PPP1R3A	6.38e-04	221	192	7	C0011860
Disease	neutrophil count, basophil count	AHI1 RREB1 ATXN2 KIT HECTD4 CREB5 SSBP4	6.91e-04	224	192	7	EFO_0004833, EFO_0005090
Disease	ER membrane protein complex subunit 4 measurement	CFB C3	8.66e-04	7	192	2	EFO_0801580
Disease	CHARGE syndrome (implicated_via_orthology)	CHD2 CHD6	8.66e-04	7	192	2	DOID:0050834 (implicated_via_orthology)
Disease	Cerebellar Diseases	AHI1 CASK	8.66e-04	7	192	2	C0007760
Disease	protein S measurement	DNAJC6 HMG20A	8.66e-04	7	192	2	EFO_0004637
Disease	Glomerulonephritis, Membranoproliferative	CFB ALB	8.66e-04	7	192	2	C0017662
Disease	large artery stroke	MBTPS1 ATXN2 OBI1 LRP1 PCCA	8.81e-04	113	192	5	EFO_0005524
Disease	eosinophil percentage of granulocytes	INPP5D ITGB8 ATXN2 ANAPC1 CREB5 PPP1R3A KANSL1	8.92e-04	234	192	7	EFO_0007996
Disease	diastolic blood pressure, unipolar depression	PLEKHG1 ATXN2 HECTD4	9.67e-04	30	192	3	EFO_0003761, EFO_0006336
Disease	Breast Cancer, Familial	BRCA2 PMS2 SLX4	9.67e-04	30	192	3	C0346153
Disease	Eczema	AHI1 INPP5D ITGB8 TM9SF2 ATXN2 ANAPC1 DNMT3A RAI1	1.01e-03	310	192	8	HP_0000964
Disease	Ependymoblastoma	NOTCH2 PMS2	1.15e-03	8	192	2	C0700367
Disease	Neuroectodermal Tumor, Primitive	NOTCH2 PMS2	1.15e-03	8	192	2	C0206663
Disease	Cerebral Primitive Neuroectodermal Tumor	NOTCH2 PMS2	1.15e-03	8	192	2	C0751675
Disease	Spongioblastoma	NOTCH2 PMS2	1.15e-03	8	192	2	C0334584
Disease	Medulloepithelioma	NOTCH2 PMS2	1.15e-03	8	192	2	C0334596
Disease	atypical hemolytic-uremic syndrome (is_implicated_in)	CFB C3	1.15e-03	8	192	2	DOID:0080301 (is_implicated_in)
Disease	myeloid white cell count	AHI1 RREB1 GGT5 ATXN2 XPO6 ATAD2B C3 KIT NOTCH2 DNMT3A STXBP5 HECTD4 CREB5 ZFHX3 SSBP4	1.28e-03	937	192	15	EFO_0007988
Disease	Alzheimer disease	ATXN7L1 INPP5D PLEKHG1 PCDH11X DOC2A ADAMTS1 FMN2 SIGLEC11 CCDC171 MYO16	1.36e-03	485	192	10	MONDO_0004975
Disease	C3 glomerulopathy	CFB C3	1.47e-03	9	192	2	C4087273
Disease	Atypical hemolytic-uremic syndrome	CFB C3	1.47e-03	9	192	2	cv:C2931788
Disease	Hemolytic-uremic syndrome	CFB C3	1.47e-03	9	192	2	cv:C0019061
Disease	Malignant tumor of prostate	BRCA2 ZFHX3	1.47e-03	9	192	2	cv:C0376358
Disease	tumor necrosis factor ligand superfamily member 14 measurement	CFB C3	1.47e-03	9	192	2	EFO_0010613
Disease	parental longevity	ATXN7L1 ATXN2 ADAMTS1 GPATCH1 HECTD4 IFI44 CREB5 ABCG1 GUCY1A2 CCDC171	1.56e-03	494	192	10	EFO_0007796
Disease	multiple myeloma (is_marker_for)	ALB FTO NOTCH2	1.65e-03	36	192	3	DOID:9538 (is_marker_for)
Disease	Atypical Hemolytic Uremic Syndrome	CFB C3	1.83e-03	10	192	2	C2931788
Disease	coronary artery disease	INPP5D CHD2 CFB PLEKHG1 R3HCC1L ATXN2 NUP210 FTO KDF1 COL6A3 HECTD4 RSBN1 GUCY1A2 LRP1 FMN2 EML1 RAI1	2.15e-03	1194	192	17	EFO_0001645
Disease	polybrominated biphenyl measurement, gestational serum measurement, fetal genotype effect measurement, polybrominated diphenyl ether measurement	LOXHD1 ZFHX3	2.23e-03	11	192	2	EFO_0007959, EFO_0007961, EFO_0007962, EFO_0007964
Disease	cocaine use	HSPA4 DNMT3A	2.23e-03	11	192	2	C3496069
Disease	gastrointestinal stromal tumor (is_implicated_in)	STIM1 KIT	2.23e-03	11	192	2	DOID:9253 (is_implicated_in)
Disease	Situs Inversus	CFAP52 ANKS3	2.23e-03	11	192	2	C0037221
Disease	autosomal dominant cerebellar ataxia (implicated_via_orthology)	ITPR1 ATXN2	2.66e-03	12	192	2	DOID:1441 (implicated_via_orthology)
Disease	event free survival time, type 1 diabetes mellitus, autoantibody measurement	ATXN2 RSBN1	2.66e-03	12	192	2	EFO_0000482, EFO_0004866, MONDO_0005147
Disease	age of onset of multiple sclerosis	ITPR1 PER2	2.66e-03	12	192	2	OBA_2001029
Disease	coffee consumption measurement, tea consumption measurement	HMG20A ATXN2 SCART1	2.95e-03	44	192	3	EFO_0006781, EFO_0010091
Disease	vital capacity	MYH2 AHI1 NBPF12 RREB1 ITGB8 ITPR1 R3HCC1L ATAD2B COL6A3 ADAMTS1 IFI44 CREB5 KANSL1 ZFHX3 SSBP4 CCDC171 MYO16	3.06e-03	1236	192	17	EFO_0004312
Disease	late-onset Alzheimers disease	ADAM18 INPP5D HMG20A USP32 ADAMTS1 ERO1A LRIG3	3.13e-03	292	192	7	EFO_1001870
Disease	alcohol and nicotine codependence	PLEKHG1 RGPD2	3.13e-03	13	192	2	EFO_0004776
Disease	putamen volume change measurement	SYDE2 MYO16	3.13e-03	13	192	2	EFO_0021495
Disease	autoimmune thrombocytopenic purpura (is_marker_for)	ALB DNMT3A	3.13e-03	13	192	2	DOID:8924 (is_marker_for)
Disease	pre-eclampsia (implicated_via_orthology)	C3 NOTCH2	3.13e-03	13	192	2	DOID:10591 (implicated_via_orthology)
Disease	fibrinogen measurement, tissue plasminogen activator measurement	ATXN2 STXBP5 HECTD4	3.15e-03	45	192	3	EFO_0004623, EFO_0004791
Disease	Acute Promyelocytic Leukemia	GLI2 KIT DNMT3A	3.35e-03	46	192	3	C0023487
Disease	Fanconi anemia	BRCA2 SLX4	3.64e-03	14	192	2	cv:C0015625
Disease	wet macular degeneration	CFB C3	3.64e-03	14	192	2	EFO_0004683
Disease	sickle cell anemia (is_marker_for)	CFB C3	3.64e-03	14	192	2	DOID:10923 (is_marker_for)
Disease	schizophrenia, anorexia nervosa	ALMS1 CREB5 FXR1	3.78e-03	48	192	3	MONDO_0005090, MONDO_0005351
Disease	mean arterial pressure, alcohol drinking	PLEKHG1 ATXN2 FTO HECTD4	3.90e-03	98	192	4	EFO_0004329, EFO_0006340
Disease	Acute Confusional Senile Dementia	INPP5D PCDH11X ADAMTS1 IDE	4.04e-03	99	192	4	C0546126
Disease	Alzheimer's Disease, Focal Onset	INPP5D PCDH11X ADAMTS1 IDE	4.04e-03	99	192	4	C0750900
Disease	Alzheimer Disease, Early Onset	INPP5D PCDH11X ADAMTS1 IDE	4.04e-03	99	192	4	C0750901
Disease	Presenile dementia	INPP5D PCDH11X ADAMTS1 IDE	4.04e-03	99	192	4	C0011265
Disease	Alzheimer Disease, Late Onset	INPP5D PCDH11X ADAMTS1 IDE	4.04e-03	99	192	4	C0494463
Disease	Anilide use measurement	KANSL1 LRP1	4.18e-03	15	192	2	EFO_0009938
Disease	Autosomal recessive primary microcephaly	STIL CEP152	4.18e-03	15	192	2	cv:C3711387
Disease	N-acetylmethionine measurement	ITPR1 ALMS1	4.18e-03	15	192	2	EFO_0021427
Disease	Familial Alzheimer Disease (FAD)	INPP5D PCDH11X ADAMTS1 IDE	4.19e-03	100	192	4	C0276496
Disease	Bipolar Disorder	NAPG ITGA9 ITPR1 PER2 BRCA2 HSPA4 TRPC7 NTRK2 TLL2	4.20e-03	477	192	9	C0005586
Disease	Cardiomyopathy, Familial Idiopathic	ALMS1 TMPO PCCA	4.25e-03	50	192	3	C1449563
Disease	Alzheimer's Disease	INPP5D PCDH11X ADAMTS1 IDE	4.34e-03	101	192	4	C0002395
Disease	TPE interval measurement	RUFY1 CREB5 LRIG3	4.74e-03	52	192	3	EFO_0004644
Disease	focal segmental glomerulosclerosis	ALMS1 GPATCH1	4.76e-03	16	192	2	EFO_0004236

Protein segments in the cluster

Peptide	Gene	Start	Entry
ADVETHFRTCHENTK	ZNF280B	416	Q86YH2
EQACHLAKTAFDDAI	YWHAG	191	P61981
ASKDETAQRCIHFFA	C2orf42	236	Q9NWW7
ANHSCENSELADLDK	EPC2	416	Q52LR7
TEQRKFLASDHCFND	CFAP61	711	Q8NHU2
QDFDHDKQEAVDRCE	CEP152	661	O94986
DRLKEIQNHFDTCEA	CEP128	421	Q6ZU80
IQNHFDTCEAERKHA	CEP128	426	Q6ZU80
DTCEAERKHADLQIS	CEP128	431	Q6ZU80
FTFHADICTLSEKER	ALB	531	P02768
LDDRVKTHLFRSEDC	CRYBG3	1436	Q68DQ2
VCHDSDESDTAKAVE	DNMT3A	386	Q9Y6K1
DETCHFQKSEAILRE	ABCG1	626	P45844
DVHKSFINSLCFDTE	AHI1	741	Q8N157
ACFKEVNSLHERSEN	ADAM18	516	Q9Y3Q7
SAHRDCEDVAKAALR	ARMC6	466	Q6NXE6
DLEQKLFDETCCEHA	CALHM3	221	Q86XJ0
THEKFESACEELNNA	CCDC171	1031	Q6TFL3
SCSKDTHALEQALDF	GRM2	91	Q14416
TDENIATKRSDHFDA	ALMS1	376	Q8TCU4
FSNSDNCREVHLEKR	APBA3	386	O96018
VSHSEDDCLAFKVHQ	C3	1451	P01024
DQKAFSVEHTSCNEE	AGGF1	296	Q8N302
ACEDAHDVKDVCLTF	ANKEF1	156	Q9NU02
FKDQDFTTLRDHCLS	CAPN13	16	Q6MZZ7
SQVDSDDVPDKCREH	DNHD1	2266	Q96M86
ETCTFAKLTHLFDND	ANO9	251	A1A5B4
TKHCDKAEFFSSENV	C1GALT1C1	91	Q96EU7
DCKRDKSVNSHSFQD	CASP8AP2	416	Q9UKL3
ADESEKLDCQFSTHH	ATXN7L1	446	Q9ULK2
RECEKNDSTADELHV	R3HCC1L	331	Q7Z5L2
ACSVHEAVFEAREQK	RCAN3	51	Q9UKA8
CEHFRSSLEDNEDDI	RCBTB2	416	O95199
FSLENHSACLDSVAK	RAI1	641	Q7Z5J4
FREEQCEAHNEFSKA	ADAMTS1	621	Q9UHI8
KDDSHRVITFANQDD	IMP4	211	Q96G21
DSSDFLDFVCHVRNK	PTPN4	826	P29074
TDCEHADSLAQAAED	LLGL1	481	Q15334
VNSDDRAKAEFHLAE	LRRC9	1356	Q6ZRR7
RDSSKLHDSLYNEDC	ANAPC1	561	Q9H1A4
NRTALHYAAEKDEAC	ASB8	86	Q9H765
TEKEDSCFELLHRAV	ASB8	201	Q9H765
VLTAAHCFTVDDKEH	CFB	521	P00751
IVKDSEADRFSDSHN	NUP210	161	Q8TEM1
SELDCSLEHEFRKAQ	CREB5	76	Q02930
CTDFDDISLLHAKNA	MSH3	166	P20585
SDHCFKNTDAAAALL	NOTCH2	1636	Q04721
TDELRRNHCFQDFKE	ELOA2	581	Q8IYF1
EIHALTDCSEKDLDF	CASK	356	O14936
TDCSEKDLDFLHSVF	CASK	361	O14936
EEGSSDCEVFSKNHA	HSPA4	411	P34932
ASERNLFISCKSSHD	TMPO	271	P42166
AEVQQECLHKFSTRD	NELFCD	41	Q8IXH7
DSNCLDDSHRQKDCF	MBTPS1	846	Q14703
DLREACSNENVHKEF	FXR2	146	P51116
SCTHISADEKAAERS	MGA	2381	Q8IWI9
RDSFICSKQEDHAEA	KIT	686	P10721
RDCVKDAVAAEVFDH	FAM149A	446	A5PLN7
CNNTSDRKHADSILE	ITPR1	1471	Q14643
KERTDFQEENHICTF	LRIG3	1086	Q6UXM1
CNEEKASDIAASEFI	MYO16	286	Q9Y6X6
FTEEFLNHSKAREAE	HMG20A	221	Q9NP66
CHVFVSEDSTKALAE	MAPK8IP1	671	Q9UQF2
DLREACANENAHKDF	FXR1	136	P51114
KHTEAEIAAACETFL	FTO	126	Q9C0B1
DETHCNKFCSEAQFE	LRP1	2726	Q07954
EDENALSIFETNCHS	ATAD2B	721	Q9ULI0
CDLVLDAAHEKSTES	ATXN2	301	Q99700
KEATDASDHSCEVDE	PPP1R2C	101	O14990
ARQEEENSICKAHDS	KCNJ5-AS1	111	Q8TAV5
VKDNSRDETFHFQCD	LOXHD1	1766	Q8IVV2
SAACHELQEADLSES	BEND2	191	Q8NDZ0
LAIQSSLDFEECAHK	CWC22	461	Q9HCG8
DFKETLIATCHFDAV	CFAP52	321	Q8N1V2
SSRFTHAKEEDDSDQ	GPATCH1	566	Q9BRR8
KVLHCQFSDNSDDEE	KIF27	636	Q86VH2
VASIFHCKRDAFSDA	PER2	211	O15055
STFDKHDLDRDCALS	RHOT1	311	Q8IXI2
AEEHVEAVNAKCASL	MYH2	1406	Q9UKX2
CEETHAELEASQKEA	MYH2	1466	Q9UKX2
QEAIEKHLDFDSRCA	CUL7	206	Q14999
NHLRKLVFDDFCDSS	OBI1	421	Q5W0B1
FITSEASERCHQEKR	NFYB	96	P25208
DLSDAAFAALHAKCE	KANSL1	911	Q7Z3B3
LQSSHCTLDEAFEDL	NSMF	311	Q6X4W1
EHEGCNKAFSNASDR	GLI2	536	P10070
SFAVSNRELCDDEKE	MSANTD3	141	Q96H12
DLDTSAIRHDCNFDK	ABCC2	621	Q92887
FLKAESECHLSEEDT	ETV5	466	P41161
TDKDADHNGRVTCFT	PCDH11X	386	Q9BZA7
LSENKEFARCLAAED	PCCA	146	P05165
AHRNAADLCTDLAEE	HECTD4	2141	Q9Y4D8
EETTEKACDRFTFLH	OC90	281	Q02509
ECFAHSSDLTEHQKI	PEG3	976	Q9GZU2
ERFFKLHQEDQACAT	NUP155	536	O75694
CSAKELDERAEQASH	KCNJ14	361	Q9UNX9
KDETTHDDRRCELLF	PPP4R3C	321	Q6ZMV5
ARKIFRECDHSQTDS	PLCD1	181	P51178
RRDFHSDTSACLKES	PPP1R3A	486	Q16821
TASLHVEEKANCFTE	OBSCN	2906	Q5VST9
AHCNFSALAKEESRT	ITGA9	901	Q13797
ENKCHFDEDQFSSES	ITGB8	496	P26012
FDEDQFSSESCKSHK	ITGB8	501	P26012
QETKQAFERCHRLSD	EXOC5	421	O00471
RTDCTDFHAEKLINA	HYDIN	4961	Q4G0P3
KDRIHCVAFVFDASS	IFI44	301	Q8TCB0
RIAVCDEDKLSHNEF	DOC2A	176	Q14183
DECSTHSHKVFADIQ	BRCA2	1911	P51587
QAAAELLAFCETHAK	GNG8	31	Q9UK08
EHSTCENEVSKSRQD	GCFC2	591	P16383
AIIFHDETSKTFACE	DOK6	81	Q6PKX4
HVCVLKDAFDFESRS	GLT1D1	31	Q96MS3
CSSVQKALFEEEDHV	CCDC3	186	Q9BQI4
DRIAECLKAYSDQEH	CHD2	1511	O14647
STDQEEKIEDVASHC	CHD6	41	Q8TD26
QAEAEEDCHSDTVRA	FBXO9	11	Q9UK97
FDTETRDSKLHIACF	CEP97	791	Q8IW35
SDDVKVESRFDEHQS	COL6A3	881	P12111
SEKSFCEEDHAALVN	DNAJC6	436	O75061
FAHAAVAADSKVCSD	GGT5	41	P36269
CRILKDNFASADVAD	ANKMY1	276	Q9P2S6
LEHCDSSEKELNFRV	DENND2C	166	Q68D51
TKHDDSSDNFCEADD	ERO1A	156	Q96HE7
EASVESNEDSDHACK	ANKS3	366	Q6ZW76
ARHAALEFFDSCVEK	DENND4B	641	O75064
ESCKDREVNAVDSEH	IDE	176	P14735
DVKCSNEAVFAADFH	EML1	366	O00423
ESERLDCFQSKHKSA	CCDC168	6981	Q8NDH2
DFDVDHFVSDCRKRV	COG2	26	Q14746
HDNFTEEAKDICRLF	GRK7	416	Q8WTQ7
SEDLLKNFNSECDTH	GTDC1	211	Q4AE62
AEENSLTETHKCFLE	FMN2	1626	Q9NZ56
CADLEKENAHFSISE	RUBCN	486	Q92622
RSDHNEEDEKACVLQ	PEX1	371	O43933
IVDHSLQDCVFSKEA	MIF4GD	41	A9UHW6
RCSYADHSNKEEIED	GUCY1A2	136	P33402
CCIDEFNSLKEHDRT	MCM9	411	Q9NXL9
EAREKEHYCLADLAS	MRPS27	41	Q92552
TKDVICFHAEDFTDV	RSBN1	616	Q5VWQ0
NSCSKNEIDIDAFRH	SYDE2	651	Q5VT97
ALKTDCQERLDHTNF	UTP20	806	O75691
EKHTCVTFIERSDEE	TLL1	186	O43897
ENIHKATCETADRER	NIN	991	Q8N4C6
VVDRKSSHDECQDAL	NBPF12	241	Q5TAG4
CAADKEVFSSFAHAQ	OGA	181	O60502
SFKTIFAEHLSDECR	RPL3L	101	Q92901
DDDACKTEDSDDIHF	RGPD2	1016	P0DJD1
ESALEFHNCRTDDKT	PRDM15	811	P57071
KDDEATHCRQCEKEF	RUFY1	641	Q96T51
EERSERECTALDAHK	NGEF	431	Q8N5V2
EFHSSCLESFVKSQE	INPP5D	751	Q92835
KASCSRHFISEDAQE	SLC9A5	616	Q14940
DCADHSRLVESKVEL	SAR1A	101	Q9NR31
ADCKASEVQEFTAEF	SHCBP1	91	Q8NEM2
FSVHQIDELAKCTSD	KDF1	251	Q8NAX2
CHSEDEKLSFEAVRN	STIM1	56	Q13586
IDKESREAISALHFC	STXBP5	786	Q5T5C0
HASEECSLEAAREEN	SLX4	226	Q8IY92
DASDNARKDFHREAE	NTRK2	576	Q16620
HSVDDFSSALKALQC	STIL	141	Q15468
DDSHCSFQDRFKKEQ	TRPA1	1081	O75762
VCDKAFRSDSRLAEH	ZNF320	361	A2RRD8
CDHENAAFKDVALVL	TOR1AIP1	496	Q5JTV8
EFTRELHTCDINDKS	MOXD1	121	Q6UVY6
EKAALEAFSAHVDFC	TMEM143	96	Q96AN5
TFSKLEDCHLQDRDL	RLF	656	Q13129
FEQAKDACLREAVAH	NAPG	51	Q99747
SEQHRFVCDTCDKAF	RREB1	311	Q92766
KQEDAAVTHSICEER	SAGE1	71	Q9NXZ1
ETDFTVHKDRVNDVC	SPTAN1	1916	Q13813
DRREACEHSGEAKAF	SSBP4	76	Q9BWG4
SESECEQEFSHSFKE	SYCP2	1031	Q9BX26
AAKCTLAARVDSFHE	PRPF31	296	Q8WWY3
RAHFFSDKDECAKDN	TLL2	726	Q9Y6L7
LTFDKAREACANEAA	STAB2	2211	Q8WWQ8
RHKEDAGVFCSESVA	SCART1	646	Q4G0T1
ETKATDCRLHNVFND	WASHC2C	71	Q9Y4E1
FKIHEADINADKDCD	SERINC3	76	Q13530
KTDDSFSDVDCHSNQ	PMS2	541	P54278
EKHCFTSNEAARDFG	THUMPD3	236	Q9BV44
SAAERHTNFCKDQSS	ZC2HC1B	131	Q5TFG8
SHTKNDRNVECSFEV	ZCCHC14	106	Q8WYQ9
ETKATDCRLHNVFND	WASHC2A	71	Q641Q2
EHLNLTEDFQSSECK	ZNF655	176	Q8N720
KDACVISSDFHERDT	TM9SF2	191	Q99805
SDCEEAFVDQSHLQA	ZNF121	91	P58317
RFSAAKDEAHNACVL	VPREB3	86	Q9UKI3
AFAHESICAEEKQHE	ZNF484	266	Q5JVG2
DKAFRSDSCLTEHQR	ZNF28	501	P17035
ECAKAFTQSSRLTDH	ZKSCAN7	471	Q9P0L1
EECDTVFSRKSHHET	ZNF860	541	A6NHJ4
PALSEKSHDEDSERC	ZNF597	311	Q96LX8
ESFALDSELACHQKS	ZNF597	376	Q96LX8
FFHKEVCESAEDTVL	ZMYND10	121	O75800
AIAECFVSKSEEFHI	PLEKHG1	186	Q9ULL1
HRVSDCEIDTDKNKS	TEX15	641	Q9BXT5
TEFFHDCTTNERKRE	XPO6	16	Q96QU8
ADCEKTAVEFANHLE	ZNF777	221	Q9ULD5
ADHVRKNERDSNCGF	PTPRH	806	Q9HD43
KRAECDSANNTFELH	USP40	516	Q9NVE5
EACKDFLASSSIFEH	ZNF772	226	Q68DY9
DHDTDLTCHVDFSRK	SIGLEC11	221	Q96RL6
EKEIAAFCAHVSELD	TBCEL	66	Q5QJ74
AFCAHVSELDLSDNK	TBCEL	71	Q5QJ74
DENRDNHIDFKEISC	USP32	241	Q8NFA0
KLADADSQRSCAFHD	ZBBX	416	A8MT70
NECTEKQRKDSFSHS	TRPC7	201	Q9HCX4
ERTHTAEKHFECKEC	ZNF283	226	Q8N7M2
DEEAARSHLKSLCFF	ZFHX3	3476	Q15911
SSVSEDDSHLKVFCE	MYO5C	346	Q9NQX4